Cannabis Market Research
South African cannabis sits in an unusual regulatory middle ground — personal cultivation and possession were decriminalised by the 2018 Constitutional Court ruling, the Cannabis for Private Purposes Act was signed in 2024, and medical cannabis licensing is established, but full commercial adult-use distribution is still constrained. Export-focused cultivators serving the EU medical market have built genuine scale, local craft brands have emerged in wellness and CBD, and product-format innovation (edibles, beverages, topicals) is accelerating faster than regulation. Research in this sector requires a clear understanding of what is legal to claim, to distribute, and to test — and what is not.
Why Cannabis Research Matters
- The regulatory environment separates medical, wellness/CBD, and private-use segments with different rules, labelling constraints, and commercial channels — research must be designed within those boundaries.
- The true scale of private-use consumption is substantially larger than formal commercial sales capture, and only primary consumer research reveals the underlying demand and product-format preferences.
- Export-focused cultivation (primarily EU medical market) is a separate commercial segment with its own competitive dynamics, GAP/GMP quality requirements, and buyer-side research needs.
- Emerging product formats (edibles, beverages, topicals, vape) sit in a regulatory grey zone in South Africa — understanding consumer acceptance and willingness-to-try is commercially important but requires ethical and legal design care.
- Cannabis consumer research is stigmatised — underreporting in survey self-report is high, and behavioural triangulation is essential to avoid building strategy on understated demand.
Our Cannabis Research Services
Consumer research under regulatory constraint
Qualitative and quantitative research designed within South African legal and advertising constraints, with appropriate ethical review.
Category and format-innovation research
Research into emerging formats (CBD wellness, edibles, beverages, topicals) including concept, taste, and pack testing where legally permissible.
Wellness and CBD positioning
Brand positioning and claim-substantiation research for the CBD wellness segment, aligned to current regulatory permissions.
Export-market feasibility (EU, UK)
Feasibility and competitive-landscape research for South African cultivators entering EU or UK medical markets.
B2B buyer and distribution research
Research with dispensary operators, wellness retailers, and export-market buyers on range, margin, and quality expectations.
Regulatory and policy landscape monitoring
Structured tracking of the evolving regulatory environment and its commercial implications.
How We Approach Research in This Sector
Cannabis research has to be designed within a regulatory and advertising regime that is still in flux, so we start every engagement with a scope alignment on what can and cannot be claimed, tested, or distributed. Ethics review is built into qualitative and quantitative work where substances or effects are referenced. For consumer work we use behavioural-triangulation techniques (e.g., list experiments, randomised-response) to reduce the systematic underreporting that affects self-report in stigmatised categories. For export and B2B work we combine South African-side cultivation research with in-market EU or UK research through partner capability.
Why Choose Meraki Research for Cannabis?
- We have run consumer and B2B research in the South African cannabis and CBD-wellness space and understand the regulatory boundaries of what can be claimed, tested, and published.
- Our methodology includes behavioural-triangulation techniques appropriate to stigmatised-category research, reducing the systematic underreporting that distorts self-report alone.
- We maintain partner capability in the UK and EU medical cannabis markets for export feasibility work.
- Our senior team includes researchers with regulatory-affairs experience adjacent to pharmaceutical and wellness categories, which is directly applicable to cannabis claim-substantiation work.
What We Deliver
| Deliverable | Format | Typical Timeline |
|---|---|---|
| Consumer segmentation study | Segment report with behavioural triangulation and commercial implications | 10-12 weeks |
| Format-innovation test | Concept and format scorecard within regulatory constraints | 6-8 weeks |
| CBD wellness positioning | Positioning territory test with claim and retail implications | 6-8 weeks |
| Export-market feasibility | EU/UK market sizing with buyer and regulatory implications | 10-12 weeks |
| B2B distribution study | Dispensary, wellness, and export-buyer interview report | 8-10 weeks |